DIRS.INFO The most relevant business & tech news

☆ New cervical cancer treatment cuts risk of death from disease, according to trial results
▼ + stars: | 2024-10-16 | by ( Sam Tupper | ) edition.cnn.com time to read: +5 min

All had locally advanced cervical cancer, although none had tumors that had spread to other organs. This discovery led to the development of an HPV vaccine that can help prevent cervical cancer in women. Brawley stressed the importance of routine cervical screening as advanced-stage cervical cancer rises among White and Black women in the US. According to the US Centers for Disease Control and Prevention, cervical cancer screenings typically test for signs of HPV that can cause cell changes on the cervix. “Of the 4,400 deaths from cervical cancer, none of them get screened every year.”Chemotherapy to treat cervical cancer can come with unpleasant side effects like nausea, vomiting and hair loss, Brawley noted.

Persons: ” Dr, Mary McCormack, “, ”, Otis Brawley, Harald zur Hausen, Brawley, White, Dr, Sanjay Gupta, It’s, ” Brawley, “ We’re Organizations: CNN, Mary McCormack of University College Hospital, Cancer Research, Johns Hopkins University, American Cancer Society, US Centers for Disease Control, CNN Health, US Food and Drug Administration Locations: Brazil, India, Italy, Mexico, United States

☆ Bladder cancer studies suggest new ways to treat the disease and improve survival
▼ + stars: | 2023-10-22 | by ( Jacqueline Howard | ) edition.cnn.com time to read: +9 min

This is one of several new studies exploring ways to improve how bladder cancer is treated. “Ever since I was in med school, a metastatic bladder cancer treatment was gemcitabine and platinum. Urothelial cancer is a type of bladder cancer that begins in the urothelial cells, which line the inside of the bladder. The drug became the first therapy targeting a genetic alteration to be approved by the FDA to treat patients with the most common type of bladder cancer, metastatic urothelial cancer. “These results support nivolumab plus cisplatin-based chemo as a new standard approach for the treatment of metastatic urothelial cancer.”

Persons: vedotin, hadn’t, ”, Thomas Powles, ” Powles, we’ve, —, Powles, Toni Choueiri, Dana, “, enfortumab, ” Choueiri, drugmaker Janssen, Dr, Sanjay Gupta, nivolumab, Matthew Galsky Organizations: CNN, Society for Medical Oncology, University of London, Barts Cancer, US, Inc, Astellas Pharma, Merck, Co, Food and Drug Administration, FDA, EMA, Lank, Genitourinary Oncology, Farber Cancer Institute, ESMO, New England, of Medicine, University of Texas, Anderson Cancer Center, US Food and Drug Administration, National Library of Medicine, CNN Health, Bristol Myers Squibb, Ono Pharmaceutical Company, Cancer, The Tisch Cancer Institute Locations: Madrid, United Kingdom, United States, Europe, Mount Sinai

☆ Drug shortages’ effects on cancer research may be felt for years to come
▼ + stars: | 2023-07-20 | by ( Jen Christensen | ) edition.cnn.com time to read: +8 min

But these shortages aren’t just bad for current patients, experts say; their effects on cancer research may be felt for years to come. The National Cancer Institute, the federal government’s main agency for cancer research and training, told CNN that at least 174 of its own trials may be affected by the shortages. Cisplatin and other platinum-based drugs are prescribed for 10% to 20% of all cancer patients, according to the National Cancer Institute. Crucial work on hold“With drug shortages, trials have become almost like an impossible task. “These drug shortages come and go, and there’s no real rhyme or reason, and there seems to be no rhyme or reason in terms of which institutions have shortages.

Persons: Joe Biden, it’s, ’ ”, Shadia Jalal, Indiana University Melvin, Jalal, She’s, they’ve, ” Jalal, “, ”, haven’t, “ We’ve, Mark Fleury, Fleury, you’re, ” Fleury, Dmitry Walker, Merck, We’ve, ” Walker, there’s, Biden, Lawrence Feldman, ” Feldman, Feldman, Dr, Sanjay Gupta, ‘ Organizations: CNN, National Cancer Institute, American Society of Health, Cancer, Indiana University, Bren Simon Comprehensive Cancer Center, Hematology, Oncology, IU School of Medicine, Hoosier Cancer Research Network, Veterans Administration, American Cancer Society Cancer Action Network, American Cancer Society, WVU Medicine, US Food, Pharmacists, National Comprehensive Cancer Network, University of Illinois Medical Center, CNN Health Locations: United States, China, Chicago

☆ U.S. seeks new suppliers of highly used cancer drug methotrexate in short supply
▼ + stars: | 2023-06-09 | by ( ) www.cnbc.com time to read: +2 min

The U.S. Food and Drug Administration said on Friday it is seeking new suppliers to ease shortages of methotrexate, one of the most commonly used cancer drugs, building on its push to shore up two other scarce chemotherapy medicines. An FDA spokesperson told Reuters the agency is looking for temporary importation options for the drug, which has been in shortage since March. Methotrexate is an injected drug used to treat a wide variety of cancers ranging from acute lymphoblastic leukemia in children, breast cancer, lung cancer, bone cancers and certain types of head and neck cancers, according to the National Cancer Institute. Last week, the FDA said it was looking for additional temporary suppliers for two other cancer chemotherapies, cisplatin and carboplatin. According to the American Society of Health-System Pharmacists, suppliers with methotrexate injections in shortage or on back order include Accord Healthcare, Fresenius Kabi, Pfizer , Teva and Hikma Pharmaceuticals .

Persons: Methotrexate, cisplatin, China's, Senators Gary Peters, Debbie Stabenow, Fresenius Kabi Organizations: . Food, Drug Administration, FDA, Reuters, National Cancer Institute, Pharmaceutical, U.S, Senators, Intas Pharmaceuticals, Healthcare, American Society of Health, System Pharmacists, Accord Healthcare, Pfizer, Teva, Hikma Pharmaceuticals Locations: United States, India, U.S

☆ FDA allows temporary import of unapproved Chinese cancer drug to ease U.S. shortage
▼ + stars: | 2023-06-02 | by ( Spencer Kimball | ) www.cnbc.com time to read: +1 min

The Food and Drug Administration has authorized the temporary importation of an unapproved chemotherapy drug from China in an effort to ease an acute shortage of cancer drugs in the United States, according to an update posted to the agency's website on Friday. The FDA told CNBC this week that the agency was considering imports of unapproved chemotherapy drugs. An FDA spokesperson said the agency assesses the quality of unapproved drug imports to make sure they are safe for U.S. patients. Doctors say some cancer patients could die if the national shortage drugs like cisplatin is not resolved soon. At least 13 other cancer drugs are in short supply across the U.S.

Organizations: Qilu Pharmaceutical, Co, Drug Administration, U.S . Health, FDA, CNBC Locations: Hainan, Haikou, Hainan Province, China, United States, U.S, Toronto, Jinan, Shandong

☆ FDA considers temporary cancer drug imports from unapproved companies to ease U.S. shortage
▼ + stars: | 2023-06-01 | by ( Spencer Kimball | ) www.cnbc.com time to read: +5 min

She is one of hundreds of Ontario cancer patients who received diluted chemotherapy in the last year and who are still undergoing treatment to beat the disease. The FDA in the past has taken similar action to loosen restrictions on imports when faced with drug shortages. At least 14 cancer drugs are currently in short supply across the U.S. Up to 20% of cancer patients rely on platinum-based chemotherapy drugs such as cisplatin and carboplatin for treatment, according to the National Cancer Institute. Some cancer patients could die if the shortages are not quickly resolved, doctors said.

Persons: Dawn Deslippe, Diane Marley, Richard Lautens, Drug Administration –, Julie Gralow, We're, Gralow, —, Abdul Rafeh Naqash, Naqash, Philip Schwieterman, Schwieterman Organizations: Windsor Regional Hospital, Toronto Star, Getty, Drug Administration, CNBC, FDA, U.S, The American Society of Clinical Oncology, World Health, Pharmaceuticals, National Cancer Institute, American Society of Clinical Oncology, Stephenson Cancer Center, University of Oklahoma, University of Kentucky, kiwis Locations: WINDSOR, Ontario, United States, U.S, carboplatin

☆ U.S. FDA approves Fennec's hearing loss therapy
▼ + stars: | 2022-09-21 | by ( ) www.reuters.com time to read: +1 min

Register now for FREE unlimited access to Reuters.com RegisterSignage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File PhotoSept 21 (Reuters) - The U.S. Food and Drug Administration has approved Fennec Pharmaceuticals Inc's (FENC.O) intravenous therapy to prevent chemotherapy-induced hearing loss in children, according to the health regulator's website. Cisplatin is used in treating a range of cancers in children such as liver, bone and brain cancer, but can cause permanent hearing loss. Register now for FREE unlimited access to Reuters.com RegisterPedmark is now the only approved therapy to prevent cisplatin-induced hearing loss in the United States, with most patients opting for either cochlear implants or hearing aids. Register now for FREE unlimited access to Reuters.com RegisterReporting by Raghav Mahobe and Mrinalika Roy in Bengaluru; Editing by Dhanya Ann ThoppilOur Standards: The Thomson Reuters Trust Principles.

Search resuls for: "cisplatin"

7 mentions found